학술논문

66P High incidence of TP53 and epigenetic modifying oncogene mutations in a large cohort of patients enrolled in phase I clinical trials for R/R DLBCL
Document Type
Abstract
Source
In Annals of Oncology October 2020 31 Supplement 5:S1237-S1237
Subject
Language
ISSN
0923-7534